| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.01B | -24.8% |
| Cost of Revenue | $269.3M | -41.2% |
| Gross Profit | $743.4M | -16.3% |
| R&D Expense | $2.6M | -15.4% |
| SG&A Expense | $701.4M | -1.2% |
| Operating Income | $1.1M | -99.1% |
| Pre-tax Income | $98.0M | -34.5% |
| Income Tax | $25.3M | -41.2% |
| Net Income | $30.8M | -71.1% |
| EPS (Basic) | $0.22 | -79.0% |
| EPS (Diluted) | $0.22 | -78.8% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.7M | -33.1% |
| Accounts Receivable | $99.1M | -21.8% |
| Current Assets | $585.8M | -21.7% |
| Total Assets | $3.10B | -8.9% |
| Current Liabilities | $910.6M | +22.0% |
| Long-term Debt | $280.0M | +173.1% |
| Total Liabilities | $1.57B | +8.8% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $401.4M | +35.4% |
| Capital Expenditures | $82.6M | +1.8% |
| Investing Cash Flow | -$102.1M | -49.1% |
| Financing Cash Flow | -$340.7M | -76.8% |
| Free Cash Flow | $318.8M | +48.0% |
| Stockholders' Equity |
| $1.53B |
| -22.0% |